John Dobak - 01 Jul 2021 Form 4 Insider Report for DermTech, Inc.

Role
Chief Executive Officer, Director
Signature
/s/ Jason S. Miller, attorney-in-fact
Issuer symbol
N/A
Transactions as of
01 Jul 2021
Net transactions value
-$513,448
Form type
4
Filing time
02 Jul 2021, 20:47:35 UTC
Previous filing
15 Jun 2021
Next filing
10 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DMTK Common Stock Sale $376,386 -9,200 -2% $40.91* 459,647 01 Jul 2021 Direct F1, F2
transaction DMTK Common Stock Sale $137,062 -3,300 -0.72% $41.53* 456,347 01 Jul 2021 Direct F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2021.
F2 This transaction was executed in multiple trades at prices ranging from $40.30 to $41.27, inclusive. The reported price reflects the weighted-average sale price.
F3 This transaction was executed in multiple trades at prices ranging from $41.34 to $41.77, inclusive. The reported price reflects the weighted-average sale price.
F4 The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) of this Form 4.